Clinical trial
Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants
NCT05493475 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants
- Lead sponsor
- Nationwide Children's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 10, 2022
- Completion date
- September 29, 2025
- Enrollment
- 653 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fentanyl overdose, harm reduction, opiate overdose